Last reviewed · How we verify
CHLORAMPHENICOL SUCCINIC ACID
CHLORAMPHENICOL SUCCINIC ACID is a drug. It is currently FDA-approved (first approved 1959).
At a glance
| Generic name | CHLORAMPHENICOL SUCCINIC ACID |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1959 |
Approved indications
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CHLORAMPHENICOL SUCCINIC ACID CI brief — competitive landscape report
- CHLORAMPHENICOL SUCCINIC ACID updates RSS · CI watch RSS
Frequently asked questions about CHLORAMPHENICOL SUCCINIC ACID
What is CHLORAMPHENICOL SUCCINIC ACID?
CHLORAMPHENICOL SUCCINIC ACID is a Small molecule drug.
When was CHLORAMPHENICOL SUCCINIC ACID approved?
CHLORAMPHENICOL SUCCINIC ACID was first approved on 1959.
What development phase is CHLORAMPHENICOL SUCCINIC ACID in?
CHLORAMPHENICOL SUCCINIC ACID is FDA-approved (marketed).